Author:
Kostis John B.,Klapholz Marc,Delaney Ms. Carol,Vesterqvist Ole,Cohen Marvin,Manning James A.,Jemal Mohammed,Kollia Georgia D.,Liao Wei-Chi
Subject
Pharmacology (medical),Pharmacology
Reference30 articles.
1. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans;Massien;Clin Pharmacol Ther,1999
2. Vasopeptidase inhibition: a new concept in blood pressure management;Burnett;J Hypertens,1999
3. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensinconverting enzyme and neutral endopeptidase;Robl;J Med Chem,1997
4. Effects of BMS-186716, a new dual metalloprotease inhibitor, on pharmacodynamic markers of neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE) activity in healthy men [abstract PIV-46];Vesterqvist;Clin Pharmacol Ther,1997
5. Pharmacodynamic effects of multiple doses of omapatrilat in healthy subjects [abstract PI-61];Vesterqvist;Clin Pharmacol Ther,1999
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献